# K221266: Cervical Spine Truss System (CSTS) Interbody Fusion Device

- Pathway: 510(k) (Traditional)
- Applicant: 4Web Medical, Inc.
- Decided: Jan 5, 2023 after 248 days
- Product code: ODP (Intervertebral Fusion Device With Bone Graft, Cervical)
- Device class: 2
- Regulation: 21 CFR 888.3080
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 23 generations back to K841189 (1984). 258 ancestors in all.
3 later devices descend from it; 1 cites it directly.
0 of 262 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K173159: Cervical Spinal Truss System (CSTS) Interbody Fusion Device, 4Web, Inc. (2018) Summary page 5.

## Most influential descendants
- K231739: Cervical Spine Truss System (CSTS) (2023), 2 descendants of its own
- K253200: Cervical Spine Truss System - Stand Alone (CSTS-SA) (2025), 0 descendants of its own
- K251117: Cervical Spine Truss System (CSTS) (2025), 0 descendants of its own

## Indications for use
The Cervical Spine Truss System (CSTS) Interbody Fusion Device is indicated for use in skeletally mature patients with Degenerative Disc Disease (DDD) of the cervical spine at one level or two contiguous disc levels. DDD is defined as discogenic back pain with degeneration of the disc confirmed by patient history and radiographic studies. CSTS Interbody Fusion Devices are used as an adjunct to fusion in the cervical spine and are placed via an anterior approach at the C2 to T1 disc levels using autograft and/or allogenic bone graft comprised of cancellous and/or corticocancellous bone gratft. Patients should have received 6 weeks of non-operative treatment prior to treatment with the devices. The device must be used with supplement fixation.

Source page: https://510kreport.com/device/K221266
Methodology: https://510kreport.com/methodology